Hospital management company Universal Health Services (NYSE:UHS) reported Q4 CY2024 results exceeding the market’s revenue expectations , with sales up 11.1% year on year to $4.11 billion. The company’s full-year revenue guidance of $17.19 billion at the midpoint came in 2.9% above analysts’ estimates. Its GAAP profit of $4.96 per share was 18.8% above analysts’ consensus estimates.
Universal Health Services (UHS) Q4 CY2024 Highlights:
Revenue: $4.11 billion vs analyst estimates of $4.01 billion (11.1% year-on-year growth, 2.6% beat)
EPS (GAAP): $4.96 vs analyst estimates of $4.17 (18.8% beat)
Adjusted EBITDA: $619.3 million vs analyst estimates of $570.2 million (15.1% margin, 8.6% beat)
Management’s revenue guidance for the upcoming financial year 2025 is $17.19 billion at the midpoint, beating analyst estimates by 2.9% and implying 8.6% growth (vs 10.8% in FY2024)
EPS (GAAP) guidance for the upcoming financial year 2025 is $19.20 at the midpoint, beating analyst estimates by 7.2%
EBITDA guidance for the upcoming financial year 2025 is $2.42 billion at the midpoint, above analyst estimates of $2.38 billion
Operating Margin: 11.5%, up from 8.9% in the same quarter last year
Free Cash Flow Margin: 10%, up from 6.6% in the same quarter last year
Same-Store Sales rose 2.2% year on year (5.6% in the same quarter last year)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.